Q5135 Inj, tyenne, 1 mg

Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1200 units per day (practitioner), rationale: Prescribing Information